Medtronic plc's latest marketcap:
As of 06/26/2025, Medtronic plc's market capitalization has reached $110.15 B. According to our data, Medtronic plc is the 164th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 110.15 B |
| Revenue (ttm) | 33.54 B |
| Net Income (ttm) | 4.66 B |
| Shares Out | 1.28 B |
| EPS (ttm) | 3.61 |
| Forward PE | 15.50 |
| Ex-Dividend Date | 06/27/2025 |
| Earnings Date | 08/19/2025 |
Medtronic plc's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $110.15 B | 7.53% | 164 |
| 12/31/2024 | $102.43 B | -6.49% | 160 |
| 12/29/2023 | $109.54 B | 5.95% | 126 |
| 12/30/2022 | $103.38 B | -25.68% | 127 |
| 12/31/2021 | $139.09 B | -11.78% | 95 |
| 12/31/2020 | $157.67 B | 3.69% | 71 |
| 12/31/2019 | $152.07 B | 24.48% | 54 |
| 12/31/2018 | $122.16 B | 11.77% | 58 |
| 12/29/2017 | $109.3 B | 11.75% | 73 |
| 12/30/2016 | $97.8 B | -9.58% | 67 |
Company Profile
About Medtronic plc
Medtronic plc is a global leader in medical technology, developing and manufacturing device-based therapies for healthcare systems, physicians, clinicians, and patients. Founded in 1949 and headquartered in Galway, Ireland, the company operates across multiple medical specialties.
Key Business Segments
-
Cardiovascular Portfolio
- Implantable cardiac pacemakers, defibrillators, and cardiac resynchronization therapy devices
- Cardiac ablation products and insertable cardiac monitors
- Aortic valves, surgical valve replacements, and endovascular stent grafts
- Percutaneous coronary intervention products and angioplasty balloons
-
Neuroscience Portfolio
- Medical devices, implants, and biologic solutions
- Spinal cord stimulation and brain modulation systems
- Implantable drug infusion systems and nerve ablation systems (Accurian)
- Products for neurosurgeons, neurologists, pain specialists, and more
-
Medical Surgical Portfolio
- Surgical stapling, vessel sealing, and wound closure products
- AI-powered surgical analytics and robotic-assisted surgery
- Hernia devices, mesh implants, and gynecology products
- Patient monitoring and airway management solutions
-
Diabetes Operating Unit
- Insulin pumps and consumables
- Continuous glucose monitoring systems
- InPen smart insulin pen system
Medtronic serves a broad range of medical professionals, including surgeons, specialists, and interventional radiologists, providing innovative solutions for complex health conditions.
Frequently Asked Questions
-
What is Medtronic plc's (MDT) current market cap?As of 06/26/2025, Medtronic plc (including the parent company, if applicable) has an estimated market capitalization of $110.15 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Medtronic plc (MDT) rank globally by market cap?Medtronic plc global market capitalization ranking is approximately 164 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.